Size | Price | Stock |
---|---|---|
500g | $55 | In-stock |
1000g | $67 | In-stock |
> 2 kg | Get quote | |
We match the lowest price on market. |
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
Cat. No. : | HY-N0210 |
M.Wt: | 180.16 |
Formula: | C6H12O6 |
Purity: | >98 % |
Solubility: | DMSO : 50 mg/mL (ultrasonic);H2O : 62.5 mg/mL (ultrasonic;warming;heat to 60°C) |
D-Galactose is a natural aldohexose and C-4 epimer of glucose.
In Vitro:Galactose is important for the survival and virulence of bacteria. In Escherichia coli galactose is utilized by the Leloir pathway. Two anomers of d-galactose are used for different purposes, α-d-galactose as a carbon source and β-d-galactose for induction of UDP-galactose synthesis for biosynthetic glycosylation[1].
In Vivo:D-Galactose can be used in animal modeling to construct mouse subacute aging model and rat cataract model.
Chronic D-galactose exposure induces neurodegeneration by enhancing caspase-mediated apoptosis and inhibiting neurogenesis and neuron migration in mice, as well as increasing oxidative damage. In addition, D-galactose-induced toxicity in mice is a useful model for studying the mechanisms of neurodegeneration and neuroprotective drugs and agents[2]. D-galactose given by oral route causes cognitive impairments in rats which are accompanied by oxidative damage. Cognitive impairments is observed in the open-field test in the 4th and 6th weeks after d-gal administration, as well as an impairment in spatial memory in the radial maze test after the 6th week of d-gal administration[3].
D-Galactose is a classic subacute aging and cataracts modeling agent. D-galactose changes the structure of protein and peptide by reacting with their free amine groups resulting in the accumulation of advanced glycation end (AGE) products through non-enzymatic glycation. AGEs give rise to age-related disorders. Rats and mice are generally used as animal models[4][5][6][7].
Dose reference for D-Galactose induction[4][5][6][7]:
(1) Model animal: female/male C57BL/6J mice
Subacute Aging Model: 50, 100 and 200 mg/kg/day, subcutaneous injection (s.c.), 8 weeks
Cataract Model: 200 mg/kg/day, subcutaneous injection (s.c.), 8 weeks
(2) Model animals: Albino-Wistar rats (120-130 g)
Subacute Aging Model: 300 mg/ml/kg, injected intraperitoneally (i.p.), 7 day
Cataract Model: 15 g/kg, injected intraperitoneally (i.p.), twice daily, 30 day
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.